Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Pheochromocytoma × fluorodopa F 18 × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1 CNS 1

Conditions

Insulinoma 2 Thyroid cancer, medullary 1 Pheochromocytoma 1 Paraganglioma 1 Neuroblastoma 1 Hypoglycemia 1 Hyperinsulinism 1 Congenital Hyperinsulinism 1 Carcinoid Tumor 1 Beckwith-Wiedemann Syndrome 1

Interventions

3-Iodobenzylguanidine 6 pegfilgrastim 1 fluorodopa F 18 1 Vorinostat 1 Potassium Iodide 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02431715 2023-02-21

18F-FDOPA PET in Neuroendocrine Tumours

British Columbia Cancer Agency

No longer available

CNSEndocrineHead & Neck

Thyroid cancer, medullary, Carcinoid Tumor, Insulinoma, Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡